Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Adc Therapeutics SA (NYSE: ADCT) was $4.04 for the day, down -3.58% from the previous closing price of $4.19. In other words, the price has decreased by -$3.58 from its previous closing price. On the day, 0.64 million shares were traded. ADCT stock price reached its highest trading level at $4.28 during the session, while it also had its lowest trading level at $3.8.
Ratios:
Our analysis of ADCT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 4.61.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on March 28, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
BofA Securities Downgraded its Neutral to Underperform on April 24, 2023, whereas the target price for the stock was revised from $7 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 07 ’24 when MALLIK AMEET sold 29,731 shares for $4.48 per share. The transaction valued at 133,195 led to the insider holds 1,167,348 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADCT now has a Market Capitalization of 403032416 and an Enterprise Value of 223179552. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.88. Its current Enterprise Value per Revenue stands at 3.252 whereas that against EBITDA is -1.507.
Stock Price History:
The Beta on a monthly basis for ADCT is 1.68, which has changed by 0.52452826 over the last 52 weeks, in comparison to a change of 0.26159418 over the same period for the S&P500. Over the past 52 weeks, ADCT has reached a high of $6.04, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is -11.19%, while the 200-Day Moving Average is calculated to be 68.37%.
Shares Statistics:
ADCT traded an average of 614.42K shares per day over the past three months and 812830 shares per day over the past ten days. A total of 82.29M shares are outstanding, with a floating share count of 59.35M. Insiders hold about 28.33% of the company’s shares, while institutions hold 45.51% stake in the company. Shares short for ADCT as of 1714435200 were 857607 with a Short Ratio of 1.40, compared to 1711584000 on 993081. Therefore, it implies a Short% of Shares Outstanding of 857607 and a Short% of Float of 1.59.
